Dihydralazine tartrate

This classification denotes an antihypertensive agent and hydrazine C8H10N6.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J9CB6K1N70, chemically known as 1,4-phthalazinedione, 2,3-dihydro-, dihydrazone, (2r,3r)-2,3-dihydroxybutanedioate (1:1), but more generally known as dihydralazine tartrate, which bears US NIH Compound Identifier 56842459. European Medicines Agency schedules Dihydralazine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01703MIG. Most nations, for tariff and trade purposes, schedule dihydralazine tartrate under HS 29339990 and SITC 51577. As of Q4 2014, DIHYDRALAZINE TARTRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC2C(C1)C(NNC2NN)NN.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.